ADC Therapeutics SA annual total assets
2019
2020
2021
2022
2023
2024
2025
ADC Therapeutics SA Total Assets Growth & History (ADCT)
ADC Therapeutics SA's total assets was $323.1M for fiscal 2025.
View full ADC Therapeutics SA company overviewADC Therapeutics SA annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $323.1M | $1.2M | +0.36% |
| 2024 | 2024-12-31 | $322.0M | −$32.8M | −9.25% |
| 2023 | 2023-12-31 | $354.8M | −$174.4M | −32.95% |
| 2022 | 2022-12-31 | $529.2M | −$88.8M | −14.37% |
| 2021 | 2021-12-31 | $618.0M | $104.3M | +20.30% |
| 2020 | 2020-12-31 | $513.7M | $376.0M | +273.10% |
| 2019 | 2019-12-31 | $137.7M | — | — |
ADC Therapeutics SA quarterly total assets
Q4.19
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $279.4M | −$42.2M | −13.12% |
| Q1 2026 | 2026-03-31 | $291.5M | $19.0M | +6.96% |
| Q4 2025 | 2025-12-31 | $323.1M | $1.2M | +0.36% |
| Q3 2025 | 2025-09-30 | $289.8M | −$59.3M | −16.99% |
| Q2 2025 | 2025-06-30 | $321.6M | −$50.2M | −13.51% |
| Q1 2025 | 2025-03-31 | $272.5M | −$35.4M | −11.50% |
| Q4 2024 | 2024-12-31 | $322.0M | −$32.8M | −9.25% |
| Q3 2024 | 2024-09-30 | $349.1M | −$117.8M | −25.23% |
| Q2 2024 | 2024-06-30 | $371.8M | −$135.5M | −26.71% |
| Q1 2024 | 2024-03-31 | $308.0M | −$159.7M | −34.15% |
| Q4 2023 | 2023-12-31 | $354.8M | −$174.4M | −32.95% |
| Q3 2023 | 2023-09-30 | $466.9M | −$64.9M | −12.20% |
| Q2 2023 | 2023-06-30 | $507.3M | −$13.2M | −2.53% |
| Q1 2023 | 2023-03-31 | $467.7M | −$114.2M | −19.63% |
| Q4 2022 | 2022-12-31 | $529.2M | −$88.8M | −14.37% |
| Q3 2022 | 2022-09-30 | $531.8M | −$106.2M | −16.65% |
| Q2 2022 | 2022-06-30 | $520.5M | $56.1M | +12.08% |
| Q1 2022 | 2022-03-31 | $581.9M | $120.2M | +26.03% |
| Q4 2021 | 2021-12-31 | $618.0M | $104.3M | +20.30% |
| Q3 2021 | 2021-09-30 | $638.0M | — | — |
| Q2 2021 | 2021-06-30 | $464.4M | — | — |
| Q1 2021 | 2021-03-31 | $461.7M | — | — |
| Q4 2020 | 2020-12-31 | $513.7M | $376.0M | +273.10% |
| Q4 2019 | 2019-12-31 | $137.7M | — | — |
ADC Therapeutics SA total assets trends
Over the last five fiscal years, ADC Therapeutics SA's total assets decreased from $513.7M to $323.1M, a change of −$190.5M. The latest reported quarter, Q2 2026, shows $279.4M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ADC Therapeutics SA source filings ↗